Phase I and Pharmacokinetic Study of Once-Daily Dosing of Intravenously Administered Busulfan in the Setting of a Reduced-Intensity Preparative Regimen and Allogeneic Hematopoietic Stem Cell Transplantation as Immunotherapy for Renal Cell Carcinoma

Author: Shaughnessy Paul   Shaughnessy Paul   Alexander Warren   Tran Hai   Ririe David   Splichal James   Pollack Marilyn   Bachier Carlos   LeMaistre Charles  

Publisher: AMSUS - Association of Military Surgeons of the U.S.

ISSN: 1930-613X

Source: Military Medicine, Vol.171, Iss.2, 2006-02, pp. : 161-165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content